Vanda Pharmaceuticals Inc...

NASDAQ: VNDA · Real-Time Price · USD
4.37
-0.06 (-1.35%)
At close: Aug 15, 2025, 3:59 PM
4.36
-0.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Vanda Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
198.77M 192.64M 254.38M 268.68M
Cost of Revenue
11.31M 14.8M 24.28M 25.63M
Gross Profit
187.46M 177.84M 230.1M 243.05M
Operating Income
-40.66M -13.95M 6.33M 42.16M
Interest Income
n/a n/a n/a 199K
Pretax Income
-22.92M 6.34M 11.3M 42.36M
Net Income
-18.9M 2.51M 6.28M 33.15M
Selling & General & Admin
146.41M 112.88M 136.49M 124.05M
Research & Development
74.43M 76.82M 85.77M 75.36M
Other Expenses
7.27M 2.09M 1.52M 1.48M
Operating Expenses
228.12M 191.8M 223.77M 200.89M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 500K 2.6M 6.7M
Cost & Expenses
239.43M 206.59M 248.05M 226.52M
Income Tax Expense
-4.02M 3.83M 5.03M 9.21M
Shares Outstanding (Basic)
58.15M 57.38M 56.46M 55.55M
Shares Outstanding (Diluted)
58.15M 57.56M 56.98M 56.92M
EPS (Basic)
-0.33 0.04 0.11 0.60
EPS (Diluted)
-0.33 0.04 0.11 0.58
EBITDA
-32.53M -10.94M 9.06M 45.01M
EBIT
-40.66M -13.95M 6.33M 42.16M
Depreciation & Amortization
8.13M 3.01M 2.73M 2.84M